In vitro cytokine secretion in individuals with schizophrenia: Results, 
confounding factors, and implications for further research

Hinze-Selch, D; Pollmächer, T

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

In vitro cytokine secretion in individuals with schizophrenia: Results, confounding factors, and implications for further research

MPS-Authors

Hinze-Selch, D
Max Planck Institute of Psychiatry, Max Planck Society;

Pollmächer, T
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Hinze-Selch, D., & Pollmächer, T. (2001). In vitro cytokine secretion in individuals with schizophrenia: Results, confounding factors, and implications for further research. Brain Behavior and Immunity, 15(4), 282-318.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-A2DA-E

Abstract

The present paper reviews the results of all publications on in vitro cytokine secretion in patients with schizophrenia, as published by March 2001. The authors supply easy to read tables with respect to the individual cytokines and soluble cytokine receptors investigated. the in vitro methodology used, characterization of the patient samples, and the results on cytokine secretion as stated in these studies. Inconsistent results. e.g., regarding in vitro secretion of IL-2 with 11/18 studies finding decreased secretion, 5/18 finding no change, and 2/18 finding increases, cannot systematically be correlated with any methodological procedures nor any diagnostic subtypes, per se. However. factors such as medication and cigarette smoking are likely to play a role. The authors suggest that more hypothesis-driven research. together with more carefully designed studies, as well as better communication between basic or animal researchers and clinicians might help to answer the question of whether there are meaningful peripheral changes in the immune system related to schizophrenia. (C) 2001 Elsevier Science